retatrutide ly3437943 glp-1 gip glucagon is the triple-agonist shaking up metabolic medicine. Activates GLP-1, GIP, and receptors in one shot. Phase 2 results: 24% body weight lost in 48 weeks—nearly double semaglutide. Key edge? 🧬 R3TA is a next-generation

Continued innovation and research into new formulations and expanded indications promise to further enhance the tools available to clinicians, paving the way for better care and quality of life for children with diabetes and obesity

10.1146/annurev.me.40.020189.002211

GLP-1 medications influence appetite and glucose regulation, but they do not independently preserve muscle mass

Melanin synthesis is triggered by UV exposure

neurology 73 (1), 129135

Initially, the agency cited shortages of semaglutide and tirzepatide the active ingredients in the popular drugs Wegovy and Zepbound and allowed pharmacies to compound these drugs under a provision for addressing drug shortages